Analyst Mani Foroohar of Leerink Partners maintained a Buy rating on RegenXBio (RGNX – Research Report), boosting the price target to $38.00. Don't Miss our Black Friday Offers: Discover the latest ...
CVS Health has added four new board members, including the CEO of a hedge fund that has been critical of the struggling ...
On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.8 which represents a decrease of $-0.22 or -3.13% from the prior close of $7.02. The stock opened at $7.05 and touched a low ...
On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $88.4 which represents a decrease of $-3.71 or -4.03% from the prior close of $92.11. The stock opened at $91.71 and ...
Leerink Partners and Cantor acted as placement agents in connection with the private placement. Don't Miss our Black Friday Offers: Published first on TheFly – the ultimate source for real-time, ...
CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. The ...
Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...
Investor's Business Daily on MSN4h
How A Side Effect Has Wiped Out Nearly 73% Of Neurogene's Value In A WeekNeurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett Syndrome ...
CVS Health has added four new board members, including the chief executive of a hedge fund that has been critical of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback